The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Open accessPublished version of a preprint
Abstract
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and therapeutics will depend on understanding viral immunity. We studied T cell memory in 42 patients following recovery from COVID-19 (28 with mild disease and 14 with severe disease) and 16 unexposed donors, using interferon-γ-based assays with peptides spanning SARS-CoV-2 except ORF1. The breadth and magnitude of T cell responses were significantly higher in severe as compared with mild cases. Total and spike-specific T cell responses correlated with spike-specific antibody responses. We identified 41 peptides containing CD4+ and/or CD8+ epitopes, including six immunodominant regions. Six optimized CD8+ epitopes were defined, with peptide-MHC pentamer-positive cells displaying the central and effector memory phenotype. In mild cases, higher proportions of SARS-CoV-2-specific CD8+ T cells were observed. The identification of T cell responses associated with milder disease will support an understanding of protective immunity and highlights the potential of including non-spike proteins within future COVID-19 vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in COVID-19 acute, mild and convalescent patients [110, 118-125].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [120]
Experimental — accuracy not yet measuredIn the citing paper
“By contrast, VAERD has not usually occurred if a TH1 cell-biased CD4+ T cell response is elicited, reflected by increased levels of interferon-γ (IFNγ), IL-2 and tumour necrosis factor (TNF)44–46,49.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [46]
In the citing paper
“Robust CD4+ and CD8+ T cell memory is induced after COVID-19,22,39, 40, 41 and multiple COVID-19 vaccines elicit CD4+ and CD8+ T cell responses.26,42, 43, 44, 45”
From Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals (2021) · cites this paper as [40]
In the citing paper
“It should be noted that all plasma and sera tested completely inhibited entry at the lowest dilution tested and that T cell responses will contribute to control of SARS-CoV-2 infection, particularly in re-infected convalescent patients (Grifoni et al., 2020; Peng et al., 2020).”
From SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) · cites this paper as Peng et al., 2020
In the citing paper
“T cell responses are detected after almost all SARS-CoV-2 infections (Grifoni et al., 2020; Rydyznski Moderbacher et al., 2020; Peng et al., 2020; Sekine et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“In SARS-CoV-2 infections, the presence of virus-specific CD8+ T cells has been associated with better COVID-19 outcomes (Rydyznski Moderbacher et al., 2020; Peng et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“Current evidence suggests an early, robust, and diverse T cell response directed against SARS-CoV-2 correlates with milder COVID-19 outcomes126,131,132”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“Severe COVID-19 has been associated with lower TCR diversity against SARS-CoV-2 epitopes131,132.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“For CD8+ T cells, there are reports of diminished CD8+ cytotoxicity and cytokine production in severe cases126,132, while others report the opposite141, and still others find no differences142.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationCryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Self-citationFolegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Self-citation
Research works printed but not linked: 1
- Fehr, A. R. & Perlman, S. in Coronaviruses. Methods in Molecular Biology Vol. 1282 (eds Maier H., Bickerton E., Britton P.) 1–23 (Humana Press, 2015).
Cited by
Sorted by citations
Items 701–800 of 1,000
Laurén, I., Havervall, S., Ng, H., Lord, M., Pettke, A., Greilert‐Norin, N., Gabrielsson, L., Chourlia, A., Amoêdo‐Leite, C., Josyula, V. S., et al. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.595 · Cited by 9
SARS-CoV-2 and Immunity: Natural Infection Compared with Vaccination
Vespa, S., Simeone, P., Catitti, G., Buca, D., Bellis, D. D., Pierdomenico, L., Pieragostino, D., Cicalini, I., Boccio, P. D., Natale, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168982 · Cited by 10
Patel, R. S., & Agrawal, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952229 · Cited by 10
Wen, Z., Yuan, Y., Zhao, Y., Wang, H., Han, Z., Li, M., Yuan, J., & Sun, C. (2023) · Viruses · doi:10.3390/v15061316 · Cited by 10
Self-citationLiu, J., Jiang, Y., Liu, Y., Pu, L., Du, C., Li, Y., Wang, X., Ren, J., Liu, W. Y., Yang, Z., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.634266 · Cited by 10
Kusnadi, A., Ramírez-Suástegui, C., Fajardo, V., Chee, S., Meckiff, B. J., Simon, H. A., Pelosi, E., Seumois, G., Ay, F., Vijayanand, P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.194027 · Cited by 10
Pérez‐Cabezas, B., Ribeiro, R. J. T., Costa, I., Esteves, S., Teixeira, A. R., Reis, T., Monteiro, R., Afonso, A., Pinheiro, V. C. A., Antunes, M. I., et al. (2021) · medRxiv · doi:10.1101/2021.01.04.20248897 · Cited by 11
Jeewandara, C., Kamaladasa, A., Pushpakumara, P. D., Jayathilaka, D., Abayrathna, I. S., Danasekara, S., Guruge, D., Ranasinghe, T., Dayarathne, S., Pathmanathan, T., et al. (2021) · medRxiv · doi:10.1101/2021.04.09.21255194 · Cited by 10
Self-citationLymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India
Suryawanshi, P. V., Patil‐Takbhate, B., Athavale, P. V., Jali, P., MEMANE, N. S., MIRZA, S. B., Karandikar, M. S., Kakrani, A. L., Kanitkar, S. A., Gandham, N. R., et al. (2023) · Viral Immunology · doi:10.1089/vim.2022.0123 · Cited by 8
Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine
Yeung, J., Wang, T., & Shi, P. (2023) · Current Opinion in Virology · doi:10.1016/j.coviro.2023.101347 · Cited by 9
Rodríguez‐Ubreva, J., Calafell-Segura, J., Calvillo, C. L., Keller, B., Ciudad, L., Handfield, L., de la Calle‐Fabregat, C., Godoy‐Tena, G., Andrés‐León, E., Hoo, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54732-x · Cited by 14
Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination
Fanti, S., Dyer, C., Ingimarsdóttir, I. J., Harding, D., Wang, G., d’Amati, A., Shahaj, E., Sigurbergsdóttir, A. Ý., Thórsdóttir, H. S., Gunnarsdóttir, O. B., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.074644 · Cited by 11
COVID-ONE-hi: The One-Stop Database for COVID-19-Specific Humoral Immunity and Clinical Parameters
Xu, Z., Li, Y., Lei, Q., Huang, L., Lai, D., Guo, S., Jiang, H., Hou, H., Zheng, Y.-X., Wang, X., et al. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.09.006 · Cited by 9
Self-citationMagalis, B. R., Mavian, C. N., Tagliamonte, M. S., Rich, S. N., Cash, M. N., Riva, A., Loeb, J. C., Norris, M. H., Amador, D. M., Zhang, Y., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27726 · Cited by 9
Self-citationWen, Z., Fang, C., Liu, X., Liu, Y., Li, M., Yuan, Y., Han, Z., Wang, C., Zhang, T., & Sun, C. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2171233 · Cited by 9
Yin, Z., Chen, J.-L., Lu, Y., Wang, B., Godfrey, L., Mentzer, A. J., Yao, X., Liu, G., Wellington, D., Zhao, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112470 · Cited by 9
Self-citationPatel, R. S., & Agrawal, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1178523 · Cited by 9
Dang, T. T. T., Anzurez, A., Nakayama‐Hosoya, K., Miki, S., Yamashita, K., de Souza, M. S., Matano, T., & Kawana‐Tachikawa, A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02143-23 · Cited by 10
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
Grandi, A., Tomasi, M., Ullah, I., Bertelli, C., Vanzo, T., Accordini, S., Gagliardi, A., Zanella, I., Benedet, M., Corbellari, R., et al. (2023) · Vaccines · doi:10.3390/vaccines11101546 · Cited by 12
Memory T Cells Discrepancies in COVID-19 Patients
AlSaihati, H., Hussein, H. A. M., Thabet, A. A., Wardany, A. A., Mahmoud, S. Y., Farrag, E. S., Mohamed, T. I. A., Fathy, S. M., Elnosary, M. E., Sobhy, A., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11112737 · Cited by 11
Breakthrough SARS-COV-2 infection induces broad anti-viral T cell immunity
Lineburg, K. E., Crooks, P., Raju, J., Texier, L. L., Khaledi, P., Berry, K., Swaminathan, S., Panikkar, A., Rehan, S., Guppy-Coles, K., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108474 · Cited by 9
Liu, Y., Li, M., Cui, T., Chen, Z., Xu, L., Li, W., Peng, Q., Li, X., Zhao, D., Valencia, C. A., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29454 · Cited by 9
Dijkstra, J. M., Frenette, A. P., & Dixon, B. (2021) · F1000Research · doi:10.12688/f1000research.51479.1 · Cited by 10
Alturaiki, W., Mubarak, A., Jurayyan, A. A., & Hemida, M. G. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1935172 · Cited by 10
An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19
Monzavi, S. M., Naderi, M., Ahmadbeigi, N., Kajbafzadeh, A. M., & Muhammadnejad, S. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104398 · Cited by 8
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients
Olea, B., Albert, E., Torres, I., Amat, P., Remigia, M. J., Gozalbo‐Rovira, R., Rodríguez‐Díaz, J., Buesa, J., Blasco, M. L., Redón, J., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104943 · Cited by 9
Boni, C., Cavazzini, D., Bolchi, A., Rossi, M., Vecchi, A. L., Tiezzi, C., Barili, V., Fisicaro, P., Ferrari, C. I., & Ottonello, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730051 · Cited by 9
Toraldo, D. M., Satriano, F., Rollo, R., Verdastro, G., Imbriani, G., Rizzo, E., Argentiero, A., Falco, A., Ambrosino, P., Miani, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262911 · Cited by 9
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine
Martínez, L., Malaina, I., Salcines-Cuevas, D., Terán-Navarro, H., Zeoli, A., Alonso, S., la Fuente, I. M. D., González-López, E., Ocejo-Vinyals, J. G., Gozalo-Margüello, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09615-w · Cited by 9
Farouq, M. A. H., Acevedo, R., Ferro, V. A., Mulheran, P. A., & Qaraghuli, M. M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116078 · Cited by 9
Möhlendick, B., Schönfelder, K., Zacher, C., Elsner, C., Rohn, H., Konik, M., Thümmler, L., Rebmann, V., Lindemann, M., Jöckel, K., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.960731 · Cited by 9
Feng, L., Lin, X., Fu, B., Xiong, Y., Zaky, M. Y., & Wu, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121374 · Cited by 12
Huang, R., Ying, L., Wang, J., Xia, J. L., Zhang, Y., Mao, H., Zhang, R., Zang, R., Le, Z., Shu, Q., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139620 · Cited by 9
Self-citationSchmidt, F., Abdesselem, H., Suhre, K., Vaikath, N. N., Sohail, M. U., Al‐Nesf, M. A., Bensmail, I., Mashood, F., Sarwath, H., Bernhardt, J., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1203723 · Cited by 9
Benchmarking SARS CoV-2 Infection in the Workplace to Support Continuity of Operations
Iddins, B. O., Waugh, M. H., Buck, B., Cato, T., Graham, D. E., Attia, K., Jones, D. R., Partin, A. M., Shourbaji, R., & Wesh, C. (2021) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002188 · Cited by 9
Bioinformatics Prediction of SARS-CoV-2 Epitopes as Vaccine Candidates for the Colombian Population
Montes‐Grajales, D., & Olivero‐Verbel, J. (2021) · Vaccines · doi:10.3390/vaccines9070797 · Cited by 9
Lin, S., Kennedy, N. A., Saifuddin, A., Sandoval, D. M., Reynolds, C. J., Seoane, R. C., Kottoor, S. H., Pieper, F. P., Lin, K., Butler, D. K., et al. (2021) · medRxiv · doi:10.1101/2021.11.10.21266168 · Cited by 9
Jennewein, M. F., Schultz, M. D., Beaver, S., Battisti, P., Bakken, J., Hanson, D., Akther, J., Zhou, F., Mohamath, R., Singh, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.10.515993 · Cited by 9
Prakash, S., Dhanushkodi, N. R., Singer, M., Quadiri, A., Zayou, L., Vahed, H., Coulon, P.-G. A., Ibraim, I. C., Tafoya, C., Hitchcock, L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.14.580225 · Cited by 10
Lett, M. J., Otte, F., Hauser, D., Schön, J., Kipfer, E. T., Hoffmann, D., Halwe, N. J., Breithaupt, A., Ulrich, L., Britzke, T., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00992-z · Cited by 8
Self-citationTargeting SARM1 as a novel neuroprotective therapy in neurotropic viral infections
He, S., Zhu, Y., Wang, X., Zhang, G., Hou, K., Xia, X., Jiang, Z., Gong, X., & Zhao, P. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03423-5 · Cited by 8
Li, X., Zhang, Y., He, L., Si, J., Qiu, S., He, Y., Wei, J., Wang, Z., Xie, L., Li, Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66369 · Cited by 8
Self-citationMeasuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management
Safont, G., Latorre, I., Villar-Hernández, R., Stojanović, Z., Marín, A., Pérez-Cano, C., Lacoma, A., Molina-Moya, B., Solis, A. J., Arméstar, F., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175103 · Cited by 8
Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
Jonny, J., Putranto, T. A., Irfon, R., & Sitepu, E. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.989685 · Cited by 13
Yasmin, S., Ansari, M. Y., Pandey, K., & Dikhit, M. R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130754 · Cited by 8
Self-citationClonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein
Sheetikov, S. A., Khmelevskaya, A. A., Zornikova, K. V., Zvyagin, I. V., Shomuradova, A. S., Serdyuk, Y. V., Shakirova, N. T., Peshkova, I. O., Titov, A., Romaniuk, D. S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1369436 · Cited by 8
García‐Torre, A., Bueno‐García, E., López‐Martínez, R., Rioseras, B., Moro‐García, M. A., Alonso, S., Lluna-González, A., Sousa-Fernández, A., Fernández-Gudin, M., Campos-Riopedre, L., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab206 · Cited by 7
Immunomodulation and immunotherapeutics of COVID-19
Garg, S. S., Sharma, A., & Gupta, J. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108842 · Cited by 8
SARS‐CoV ‐2 vaccination and practical points in psoriasis patients: A narrative review
Aryanian, Z., Balighi, K., Hatami, P., Goodarzi, A., Aghazadeh, N., & Afshar, Z. M. (2022) · Dermatologic Therapy · doi:10.1111/dth.15430 · Cited by 8
Huang, W., Weng, S., Tzeng, H., Yen, F.-C., Chiang, Y.-S., & You, H. (2022) · Vaccines · doi:10.3390/vaccines10091550 · Cited by 8
Kinetics of Immune Subsets in COVID-19 Patients Treated with Corticosteroids
Pappas, A., Chaliasou, A.-L., Panagopoulos, A., Dede, K., Daskalopoulou, S., Moniem, E. H. M. A. A., Polydora, E., Grigoriou, E., Psarra, K., Tsirogianni, A., et al. (2022) · Viruses · doi:10.3390/v15010051 · Cited by 8
Mahalingam, S. S., Jayaraman, S., Arunkumar, A., Dudley, H. M., Anthony, D. D., Shive, C. L., Jacobson, J. M., & Pandiyan, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1231087 · Cited by 7
SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines
León-Rodríguez, S. G. D., Hernández-Rico, B., Olmo-Vázquez, G. D., Cruz-Dávalos, I., & Bonifaz, L. C. (2020) · Boletín Médico del Hospital Infantil de México · doi:10.24875/bmhim.200001911 · Cited by 8
Collora, J. A., Liu, R., Albrecht, K., & Ho, Y. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000655 · Cited by 8
SARS-CoV-2 Spike-Derived Peptides Presented by HLA Molecules
Nguyen, A., Szeto, C. W., Jayasinghe, D., Lobos, C. A., Halim, H., Chatzileontiadou, D. S. M., Grant, E. J., & Gras, S. (2021) · Biophysica · doi:10.3390/biophysica1020015 · Cited by 10
The Binary Model of Chronic Diseases Applied to COVID-19
Elkoshi, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716084 · Cited by 8
Mandala, W. L., & Liu, M. K. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.797117 · Cited by 7
Usai, C., Gibbons, J. M., Pade, C., Li, W., Jacobs, S. R. M., McKnight, Á., Kennedy, P. T. F., & Gill, U. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.813300 · Cited by 8
Schulien, I., Kemming, J. S., Oberhardt, V., Wild, K., Seidel, L. M., Killmer, S., Sagar, Daul, F., Lago, M. S., Decker, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.13.249433 · Cited by 8
Clark, J. J., Sharma, P., Bentley, E. G., Harding, A. C., Kipar, A., Neary, M., Box, H., Hughes, G. L., Patterson, E. I., Sharp, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.10.434447 · Cited by 7
Kilpeläinen, A., Jiménez‐Moyano, E., Blanch-Lombarte, O., Ouchi, D., Peña, R., Quirant‐Sánchez, B., Chamorro, A., Blanco, I., Martínez-Cáceres, E. M., Paredes, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.04.438781 · Cited by 8
Namuniina, A., Muyanja, E., Biribawa, V. M., Okech, B. A., Ssemaganda, A., Price, M. A., Hills, N. K., Nanteza, A., Bagaya, B. S., Weiskopf, D., et al. (2023) · medRxiv · doi:10.1101/2023.01.16.23284626 · Cited by 8
Weisbrod, L., Capriotti, L., Hofmann, M., Spieler, V., Dersch, H., Voedisch, B., Schmidt, P. M., & Knake, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386160 · Cited by 7
Hojo-Souza, N. S., de Castro, J. T., Rivelli, G. G., de Azevedo, P. O., Oliveira, E. R., Faustino, L., Salazar, N., Bagno, F. F., de Carvalho, A. F., Rattis, B. A. D. C., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126394 · Cited by 7
Leong, R. W. L., Sakiris, A. S., Arzivian, A., Chetwood, J. D., Chaemsupaphan, T., Sparrow, M., Kamm, M. A., Kariyawasam, V. C., & the Australian IBD Consensus Working Group (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18318 · Cited by 9
Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity
Karmakar, D., Lahiri, B., Ranjan, P., Chatterjee, J., Lahiri, P., & Sengupta, S. (2020) · Pathogens · doi:10.3390/pathogens10010005 · Cited by 8
Massanella, M., Martín-Urda, A., Mateu, L., Marín, T., Aldás, I., Riveira‐Muñoz, E., Kipelainen, A., Jiménez‐Moyano, E., de la Concepción, M. L. R., Ávila‐Nieto, C., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab329 · Cited by 7
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets
Hachim, A., Kavian, N., & Valkenburg, S. A. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.08.006 · Cited by 7
Aleksova, M., Todorova, Y., Emilova, R., Baymakova, M. P., Yancheva, N., Andonova, R., Zasheva, A., Grifoni, A., Weiskopf, D., Sette, A., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13071280 · Cited by 7
Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine
Valiate, B. V. S., de Castro, J. T., Marçal, T. G., Andrade, L. A. F., Oliveira, L. I., MAIA, G. B. F., Faustino, L., Hojo-Souza, N. S., dos Reis, M. A. A., Bagno, F. F., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110177 · Cited by 7
Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents
Wang, X., Zhang, J., Liu, M., Guo, Y., Guo, P., Yang, X., Shang, B., Li, M., Tian, J., Zhang, T., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01876-3 · Cited by 7
Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants
Deng, S., Xu, Z., Wang, M., Hu, J., Liu, Z., Zhu, F., Zheng, P., Kombe, A. J. K., Zhang, H., Wu, S., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107563 · Cited by 9
Sowndharya, C. K., Mehnath, S., Ponbharathi, A., & Jeyaraj, M. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00619 · Cited by 8
Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population
Biswas, A., Mandal, R. S., Chakraborty, S., & Maiti, G. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1925267 · Cited by 7
Impact of immunosuppression on the immune response to SARS‐CoV‐2 infection: A mechanistic study
Hall, V. G., Ferreira, V. H., Kumar, D., & Humar, A. (2021) · Transplant Infectious Disease · doi:10.1111/tid.13743 · Cited by 6
Gazzinelli-Guimarães, P. H., Sanku, G., Sette, A., Weiskopf, D., Schaughency, P., Lack, J., & Nutman, T. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883159 · Cited by 7
Pandey, A., Madan, R., & Singh, S. (2022) · Current Microbiology · doi:10.1007/s00284-022-03003-3 · Cited by 7
Lani, R., Senin, N. A., AbuBakar, S., & Hassandarvish, P. (2022) · Vaccines · doi:10.3390/vaccines10101606 · Cited by 6
Li, J., Reinke, S., Yu, S., Schollmeyer, L., Liu, Y.-C., Wang, Z., Hardt, S., Hipfl, C., Hoffmann, U., Frischbutter, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1004656 · Cited by 7
Garofalo, E., Biamonte, F., Palmieri, C., Battaglia, A. M., Sacco, A., Biamonte, E., Neri, G., Antico, G. C., Mancuso, S., Foti, G., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281444 · Cited by 7
Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics
Sayahinouri, M., Firouz, S. M., Sadrabadi, A. E., Masoudnia, M., Abdolahi, M., Jafarzadeh, F., Nouripour, M., Mirzazadeh, S., Zangeneh, N., Jalili, A., et al. (2023) · Bioimpacts · doi:10.34172/bi.2023.23839 · Cited by 8
Ng, H. M., Lei, C. L., Fu, S., Li, E., Leong, S. I., Nip, C. I., Choi, N. M., Lai, K. S., Tang, X., Lei, C. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1131985 · Cited by 6
LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters
de Moor, W. R. J., Williamson, A., Schäfer, G., Douglass, N., Gers, S., Sutherland, A. D., Blumenthal, M. J., Margolin, E., Shaw, M. L., Preiser, W., et al. (2023) · Viruses · doi:10.3390/v15071409 · Cited by 7
Targeting B cells in multiple sclerosis
Sellebjerg, F. T., & Weber, M. S. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000938 · Cited by 7
Vivekanandam, R., Rajagopalan, K., Jeevanandam, M., Ganesan, H., Jagannathan, V., Christyraj, J. D. S., Kalishwaralal, K., Christyraj, J. R. S. S., & Mohan, M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1993338 · Cited by 7
Hikichi, T., Sakamoto, M., Harada, M., Saito, M., Yamane, Y., Tokumura, K., & Nakamura, Y. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01013-4 · Cited by 7
The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
Wang, Y., Qin, T., & Ye, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.953022 · Cited by 7
Noval, M. G., Kaczmarek, M. E., Koide, A., Rodriguez-Rodriguez, B. A., Louie, P., Tada, T., Hattori, T., Panchenko, T., Romero, L. A., Teng, K. W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.15.252353 · Cited by 7
Vaccination reshapes the virus-specific T cell repertoire in unexposed adultsPreprint
Pan, Y., Aiamkitsumrit, B., Bartolo, L., Wang, Y., Lavery, C. L. M., Marc, A., Holec, P. V., Rappazzo, C. G., Eilola, T., Gimotty, P. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.01.322958 · Cited by 7
Sieling, P. A., Zakin, L., Shin, A., Morimoto, B., Adisetiyo, H., Garbán, H., Liu, P., Rice, A., Taft, J. D., Patel, R. S., et al. (2020) · medRxiv · doi:10.1101/2020.11.04.20225417 · Cited by 7
In Silico T Cell Epitope Identification for SARS-CoV-2: Progress and PerspectivesPreprint
Sohail, M. S., Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3720371 · Cited by 7
The impact of viral mutations on recognition by SARS-CoV-2 specific T-cellsPreprint
de Silva, T. I., Liu, G., Lindsey, B. B., Dong, D., Shah, D. R., Mentzer, A. J., Angyal, A., Brown, R. L., Parker, M. D., Ying, Z., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.08.438904 · Cited by 7
Self-citationHigh-throughput Mutational Surveillance of the SARS-CoV-2 Spike GenePreprint
Özkan, E., Strobl, M. M., Novatchkova, M., Yelagandula, R., Albanese, T. G., Tříska, P., Endler, L., Penz, T., Patocka, T., Felsenstein, V., et al. (2021) · medRxiv · doi:10.1101/2021.07.22.21259587 · Cited by 6
Halvorson, T., Ivison, S. M., Huang, Q., Ladua, G. K., Yotis, D. M., Mannar, D., Subramaniam, S., Ferreira, V. H., Kumar, D., Belga, S., et al. (2023) · Transplantation · doi:10.1097/tp.0000000000004873 · Cited by 6
Komlódi-Pásztor, E., Escarra‐Senmarti, M., Bazer, D. A., Bhatnagar, A., Heydrich, C. A. P., Messmer, M., Ambinder, R. F., Gladstone, D. E., Clayton, L., Goodrich, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433442 · Cited by 5
SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform
Kuroda, M., Halfmann, P., Uraki, R., Yamayoshi, S., Kim, T., Armbrust, T. A., Spyra, S., Dahn, R., Babujee, L., & Kawaoka, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-59533-4 · Cited by 6
Fenn, J. R., Koycheva, A., Kundu, R., Tolosa-Wright, M., Wang, L., Narean, J. S., Conibear, E., Hakki, S., Jonnerby, J., Baldwin, S., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105795 · Cited by 6
T cells responses after vaccination: a regulatory perspective
Buoninfante, A., & Cavaleri, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584738 · Cited by 8
Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients
Jordan, S. C., Shin, B., Gadsden, T. M., Chu, M., Petrosyan, A., Vo, A. A., Ammerman, N., Sethi, S., Najjar, R., Huang, E., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003957 · Cited by 6
Qin, T., Guo, E., Lu, F., Fu, Y., Liu, S., Xiao, R., Wu, X. Y., Liu, C., He, C., Wang, Z., et al. (2021) · Aging · doi:10.18632/aging.203739 · Cited by 6
Self-citation
Metadata
- Authors
- Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., López-Camacho, C., Slon-Campos, J., Zhao, Y., Stuart, D. I., Paesen, G. C., Grimes, J. M., Antson, A. A., Bayfield, O. W., Hawkins, D. E. D. P., Ker, D.-S., Wang, B., Turtle, L., Subramaniam, K., Thomson, P., Zhang, P., Dold, C., Ratcliff, J., Simmonds, P., de Silva, T., Sopp, P., Wellington, D., Rajapaksa, U., Chen, Y.-L., Salio, M., Napolitani, G., Paes, W., Borrow, P., Kessler, B. M., Fry, J. W., Schwabe, N. F., Semple, M. G., Baillie, J. K., Moore, S. C., Openshaw, P. J. M., Ansari, M. A., Dunachie, S., Barnes, E., Frater, J., Kerr, G., Goulder, P., Lockett, T., Levin, R., Zhang, Y., Jing, R., Ho, L.-P., Oxford Immunology Network Covid-19 Response T cell Consortium, Barnes, E., Dong, D., Dong, T., Dunachie, S., Frater, J., Goulder, P., Kerr, G., Klenerman, P., Liu, G., McMichael, A., Napolitani, G., Ogg, G., Peng, Y., Salio, M., Yao, X., Yin, Z., ISARIC4C Investigators, Kenneth Baillie, J., Klenerman, P., Mentzer, A. J., Moore, S. C., Openshaw, P. J. M., Semple, M. G., Stuart, D. I., Turtle, L., Cornall, R. J., Conlon, C. P., Klenerman, P., Screaton, G. R., Mongkolsapaya, J., McMichael, A., Knight, J. C., Ogg, G., & Dong, T.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- University of York (GB)
- University of Liverpool (GB)
- University of Sheffield (GB)
- ProImmune (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
- Worthing Hospital (GB)
- Capital Medical University (CN)
- University of Edinburgh (GB)
- Siriraj Hospital (TH)
- ORCID
- Dejnirattisai, Wanwisa
- Supasa, Piyada
- Liu, Chang
- López-Camacho, César
- Slon-Campos, Jose
- Zhao, Yuguang
- Paesen, Guido C.
- Grimes, Jonathan M.
- Antson, Alfred A.
- Bayfield, Oliver W.
- Hawkins, Dorothy E. D. P.
- Ker, De-Sheng
- Wang, Beibei
- Subramaniam, Krishanthi
- Thomson, Paul
- Zhang, Ping
- Dold, Christina
- Ratcliff, Jeremy
- Simmonds, Peter
- de Silva, Thushan
- Wellington, Dannielle
- Rajapaksa, Ushani
- Chen, Yi-Ling
- Paes, Wayne
- Borrow, Persephone
- Kessler, Benedikt M.
- Fry, Jeremy W.
- Ansari, M. Azim
- Zhang, Yonghong
- Ho, Ling-Pei
- Cornall, Richard J.
- Screaton, Gavin R.
- Mongkolsapaya, Juthathip
- Knight, Julian C.
- Venue
- Nature Immunology
- Published
- 2020-09-04
- Volume
- 21
- Issue
- 11
- Pages
- 1336-1345
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC7611020
- OpenAlex
- W3082438395
- Cited by
- 1,179
- References
- 42
- Citations by year
- 2026: 41 · 2025: 68 · 2024: 118 · 2023: 171 · 2022: 291 · 2021: 398 · 2020: 91
- FWCI
- 30.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Immunology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Oxford University Research Archive (ORA) (University of Oxford) (acceptedVersion)
- PubMed Central (submittedVersion)
- Funders
- RCUK | Medical Research Council (MC_PC_19059)
- Chinese Academy of Medical Sciences (2018-I2M-2-002)
- China Scholarship Council
- Wellcome Trust (205228/Z/16/Z, 110058/Z/15/Z, 215091/Z/18/Z, 095541/A/11/Z, award 206377 to AAA)
- DH | NIHR | Health Services Research Programme (NIHR200907, CO-CIN-01)
- University of Liverpool
- University of Oxford
- University of Edinburgh
- DH | National Institute for Health Research (NIHR200927 /WHRG_P82523, NIHR201385 / WHRR P84026, NIHR200907)
- Imperial College London (IS-BRC-1215-20013)
- Worthing Hospital
- Oxford University Hospitals NHS Trust
- National Institutes of Health, National Key R&D Program of China
- University of York
- ProImmune Ltd
- Bill and Melinda Gates Foundation (MC_PC_19059)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, T cell memory, CD4+ T cells, CD8+ T cells, epitope mapping, immunodominant epitopes, spike protein, disease severity, convalescent patients, central memory T cells, effector memory T cells, antiviral immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
